Tagrisso 80mg (Osimertinib) Tablets

$4,200.00 $4,000.00

Tagrisso 80mg (osimertinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tagrisso is used to treat a certain type of non-small cell lung cancer.

Name: Tagrisso

Dosage : 80 mg

Packing : 30 tablets box

Product form: tablets


Tagrisso 80mg (osimertinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tagrisso is used to treat a certain type of non-small cell lung cancer.

How Tagrisso 80mg Is Given

Tagrisso 80mg (osimertinib) is a pill, taken by mouth, one daily. It can be taken with or without food.
Take osimertinib exactly as prescribed.
Try to swallow osimertinib tablets whole.
If you cannot swallow osimertinib tablets whole:
Plase your dose of osimertinib in a container that contains 2 ounces of water. Do not use carbonated water or any other liquids
Stir the osimertinib tablet and water until the tablet is in small pieces (the tablet will not completely dissolve). Do not crush or heat.
Drink the osimertinib and water mixture right away.
Add 4 to 8 ounces of water to the container and drink to make sure you take your full dose.
Do not change your dose or stop osimertinib unless your health care provider tells you to.
If you miss a dose, skip the missed dose and take your next dose at your regular time.
Do not take more than 1 dose of osimertinib at one time. Call your health care provider right away if you take too much.

The amount of osimertinib that you will receive depends on many factors, your general health or other health problems, and the type of cancer or condition being treated. Higher doeses do not give a better response and may cause increased toxicity. Your doctor will determine your dose and schedule.
Side Effects:

Important things to remember about the side effects of Tagrisso 80mg (osimertinib):

Most people do not experience all of the side effects listed.
Side effects are often predictable in terms of their onset and duration.
Side effects are almost always reversible and will go away after treatment is complete.
There are many options to help minimize or prevent side effects.
There is no relationship between the presence or severity of side effects and the effectiveness of the medication.

The following side effects are common (occuring in greater than 30%) for patients taking Tagrisso 80mg:

Decrease in white blood cells (total number; cells needed to fight infection)
Low platelets
Skin rash
Neutroipenia (decrease in neutrophils- a type of white blood cell)
Dry skin

These side effects are less common side effects (occuring in about 10-29%) of patients receiving osimertinib:

Low sodium
Nail changes
High magnesium levels
Eye disorder (including dry eyes, blurred vision, keratitis, cataract, eye irritation, blepharitis, eye pain, increase tear production, floaters)
Decreased appetite
Back pain
Mouth sores

Not all side effects are listed above. Some that are rare (occuring in less than 10% of patients) are not listed here. However, you should always inform your health care provider if you experience any unusual symptoms.


Before starting Tagrisso 80mg treatment, make sure you tell your doctor about any other medications you are taking (including prescriptions, over-the-counter, vitamins, herbal remedies, etc.). Do not take aspirin, or products containing aspirin unless your doctor specifically permits this.
Do not receive any kind of immunization or vaccination without your doctor’s approval while taking osimertinib.
Inform your health care professional if you are pregnant or may be pregnant prior to starting this treatment. Osimertinib may be hazardous to the fetus. Women who are pregnant or become pregnant must be advised of the potential hazard to the fetus.
For both men and women: Do not conceive a child (get pregnant) while taking osimertinib. Women of child bearing age should use effective contraception during therapy and for 6 weeks after the last dose of osimertinib. Males should also use effective contraception during therapy and for 4 months after the last dose of osimertinib. Discuss with your doctor when you may safely become pregnant or conceive a child after therapy.
Do not breast feed while taking this medication. Contact us for any inquiry


There are no reviews yet.

Be the first to review “Tagrisso 80mg (Osimertinib) Tablets”

Your email address will not be published. Required fields are marked *

Mini Cart 0

Your cart is empty.

Select your currency
USD United States (US) dollar
EUR Euro